Literature DB >> 16570073

Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19.

Marcela Karey Tello-Ruiz1, Christine Curley, Terrye DelMonte, Cosmas Giallourakis, Andrew Kirby, Kathryn Miller, Gary Wild, Albert Cohen, Diane Langelier, Anna Latiano, Neils Wedemeyer, Eric Lander, Stefan Schreiber, Vito Annese, Mark J Daly, John D Rioux.   

Abstract

Evidence from four independent linkage studies and two meta-analyses of genome-wide data support the existence of a locus conferring susceptibility to inflammatory bowel diseases (IBD) in chromosomal region 19p. Identification of a susceptibility allele in this approximately 28.5 Mb region with over 600 genes is a formidable task. To tackle this problem, we undertook two approaches: (1) haplotype-based candidate-gene screen, and (2) evaluation of previously reported associations. For the former, we selected genes with potential implication in IBD pathogenesis based on published functional and expression data, typed SNPs, constructed haplotypes, screened for association in 180 IBD trios, and followed up preliminary associations in 343 IBD patients and 207 control individuals. Overall, we analyzed 465 SNPs, and 260 haplotypes distributed across 56 candidate genes. We found suggestive evidence of association (nominal P<0.01) with four genes (C3, FCER2, IL12RB1, and CRLF1) in a screening stage, but were unable to confirm these preliminary observations at follow-up. In the second approach, we typed four nonsynonymous polymorphisms in genes C3 (R102G and L314P) and ICAM1 (G241R and K469E) in four independent cohorts totaling 2178 IBD cases. We evaluated these data together with previously published reports for three of these variants (C3-Gly102, ICAM1-Arg241, and ICAM1-Glu469), in a meta-analysis. Our pooled meta-analysis provides compelling evidence against association of these variants with disease. Overall, we performed the most comprehensive candidate-gene association study for IBD to date. The information hereby generated constitutes a valuable resource to investigate other common genetic immune diseases, such as celiac disease.

Entities:  

Mesh:

Year:  2006        PMID: 16570073     DOI: 10.1038/sj.ejhg.5201612

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  11 in total

Review 1.  CD23/FcεRII: molecular multi-tasking.

Authors:  M Acharya; G Borland; A L Edkins; L M Maclellan; J Matheson; B W Ozanne; W Cushley
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

2.  Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability.

Authors:  Timothy C Cheung; Ken Coppieters; Hideki Sanjo; Lisa M Oborne; Paula S Norris; Amy Coddington; Steven W Granger; Dirk Elewaut; Carl F Ware
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

3.  Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis.

Authors:  P Goyette; C Lefebvre; A Ng; S R Brant; J H Cho; R H Duerr; M S Silverberg; K D Taylor; A Latiano; G Aumais; C Deslandres; G Jobin; V Annese; M J Daly; R J Xavier; J D Rioux
Journal:  Mucosal Immunol       Date:  2008-01-16       Impact factor: 7.313

Review 4.  Lymphotoxin network pathways shape the tumor microenvironment.

Authors:  Ryan L Bjordahl; Christian Steidl; Randy D Gascoyne; Carl F Ware
Journal:  Curr Opin Immunol       Date:  2013-01-20       Impact factor: 7.486

5.  Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis.

Authors:  E A M Festen; P Goyette; R Scott; V Annese; A Zhernakova; J Lian; C Lefèbvre; S R Brant; J H Cho; M S Silverberg; K D Taylor; D J de Jong; P C Stokkers; D Mcgovern; O Palmieri; J-P Achkar; R J Xavier; M J Daly; R H Duerr; C Wijmenga; R K Weersma; J D Rioux
Journal:  Gut       Date:  2009-02-06       Impact factor: 23.059

6.  MAST3: a novel IBD risk factor that modulates TLR4 signaling.

Authors:  C Labbé; P Goyette; C Lefebvre; C Stevens; T Green; M K Tello-Ruiz; Z Cao; A L Landry; J Stempak; V Annese; A Latiano; S R Brant; R H Duerr; K D Taylor; J H Cho; A H Steinhart; M J Daly; M S Silverberg; R J Xavier; J D Rioux
Journal:  Genes Immun       Date:  2008-07-24       Impact factor: 2.676

7.  Genes involved in the metabolism of poly-unsaturated fatty-acids (PUFA) and risk for Crohn's disease in children & young adults.

Authors:  Irina Costea; David R Mack; David Israel; Kenneth Morgan; Alfreda Krupoves; Ernest Seidman; Colette Deslandres; Philippe Lambrette; Guy Grimard; Emile Levy; Devendra K Amre
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

8.  A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease.

Authors:  Eleonora A M Festen; Philippe Goyette; Todd Green; Gabrielle Boucher; Claudine Beauchamp; Gosia Trynka; Patrick C Dubois; Caroline Lagacé; Pieter C F Stokkers; Daan W Hommes; Donatella Barisani; Orazio Palmieri; Vito Annese; David A van Heel; Rinse K Weersma; Mark J Daly; Cisca Wijmenga; John D Rioux
Journal:  PLoS Genet       Date:  2011-01-27       Impact factor: 5.917

Review 9.  Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review.

Authors:  Isabelle Cleynen; Peter Jüni; Geertruida E Bekkering; Eveline Nüesch; Camila T Mendes; Stefanie Schmied; Stefan Wyder; Eliane Kellen; Peter M Villiger; Paul Rutgeerts; Séverine Vermeire; Daniel Lottaz
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

10.  Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence.

Authors:  Xun Chu; Yan Dong; Min Shen; Lingling Sun; Changzheng Dong; Yi Wang; Beilan Wang; Kaiyue Zhang; Qi Hua; Shijie Xu; Wei Huang
Journal:  BMC Med Genet       Date:  2009-03-13       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.